An Audience With

Filter By:

Article Type
Year

  • The Head of the Clinical Trials Unit at the Paul Ehrlich Institute in Germany discusses the progress of a 'one stop shop' to assess applications for multinational clinical trials in Europe.

    An Audience With

  • The first executive dean for research at Harvard Medical School discusses the aims and challenges of his newly created position.

    An Audience With

  • The Executive Director of US think tankFasterCuresdiscusses how the organization acts as a catalyst to accelerate the development of innovative therapies.

    An Audience With

  • A pioneer of evidence-based medicine discusses how mathematical models can be used to understand the likely cost and health-care outcomes of therapies.

    • Bethan Hughes
    An Audience With

  • The Chairman and former Chief Executive Officer of Novartis discusses the company's approach to R&D.

    • Bethan Hughes
    An Audience With

  • The Executive Vice President of R&D at Sanofi–Aventis discusses the company's R&D strategy.

    • Bethan Hughes
    An Audience With

  • The Commissioner for Patents at the United States Patent and Trademark Office discusses the challenges that he faces as he takes up his new appointment.

    • Charlotte Harrison
    An Audience With

  • The President and Chief Executive Officer of the Austen BioInnovation Institute in Akron discusses the institute's multidisciplinary approach to innovation.

    An Audience With

  • Genentech's Vice President of Neuroscience discusses the company's renewed interest in the area.

    An Audience With

  • The Chairman of the UK's National Institute for Health and Clinical Excellence discusses the UK's payer environment.

    An Audience With

  • Millennium's Chief Scientific Officer discusses the company's approach to anticancer drug development.

    • Bethan Hughes
    An Audience With

  • MedImmune's Executive Vice President of R&D shares his excitement about the therapeutic potential of novel biologics.

    An Audience With

  • The former President of the Pharmaceutical Research Division of Warner-Lambert (Parke-Davis Company) discusses the effect of mega-mergers on pharmaceutical innovation.

    An Audience With

  • GSK's Head of R&D China discusses progress so far at the R&D site established in Shanghai in June 2007.

    An Audience With

  • The Chair of the EMEA's new Committee for Advanced Therapies discusses the challenges of developing such products.

    • Bethan Hughes
    An Audience With

  • Chief Scientific Officer of Pfizer Regenerative Medicine discusses Pfizer's move into stem-cell-based therapies.

    An Audience With

  • Former Centers for Medicare and Medicaid Services administrator and FDA commissioner discusses healthcare reform in the US

    An Audience With

  • Lilly's Executive Vice President of Science and Technology, discusses the company's R&D strategy.

    An Audience With

  • The founder of PureTech Ventures discusses the firm's unique approach to company creation.

    An Audience With

  • The President of the Critical Path Institute discusses the successes to date and future challenges of helping the FDA to improve the process for developing safe, innovative drugs.

    An Audience With